Large-scale testing (Phase 3)Study completedNCT02267135
What this trial is testing
Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis
Who this might be right for
Chronic Scalp Psoriasis
Novartis Pharmaceuticals 102